Tiêm phòng vẫn là cách tốt nhất để bảo vệ trẻ ở độ tuổi đến trường

Theo Tiến sỹ Abraar Karan, một chuyên gia vật lý về bệnh truyền nhiễm tại Đại học Stanford, hầu hết trẻ em mắc COVID-19 hoặc tiêm vaccine gần đây có đủ miễn dịch để bảo vệ mình khỏi virus trong nhiều tuần hoặc lâu hơn, và việc kết hợp của vaccine và việc mắc COVID-19 tạo kháng thể mạnh hơn.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh